Lisa J. Kim, NP, Accepts Offer To Join Section

It is with great pleasure to announce Lisa J. Kim, NP, has accepted an offer to join our section. Lisa will be working as a dedicated stem cell transplant program nurse practitioner, reporting directly to Vaishali Sanchorawala, MD, as the Program Director. Lisa will bring to our section a broad range of prior experience that […]

Gerald Denis, PhD, Promoted to Professor of Medicine and Pharmacology

We are delighted to announce that Gerald Denis, PhD, has been promoted to the rank of Professor of Medicine and Pharmacology. Gerald is a noted expert in the field of BET bromodomain proteins, and his work has gained broad influence nationally and internationally in the emerging areas of obesity and metabolism. Gerald has made numerous […]

Heme Onc Faculty Receive Grant Funding from BU CTSI

  We are thrilled to share the exciting news that five of our Heme/Onc faculty members were recently selected to receive grant funding from the BU CTSI. Our awardees are: Gareth Morgan, PhD, for “Single Cell Analysis of AL Amyloidosis in Plasma Cells”         Naomi Ko, MD, for “Clinical Pipeline for Single […]

Elliott Hagedorn, PhD, Accepts Offer To Join Section

We are delighted to announce that Elliott Hagedorn, PhD, has accepted an offer to join the section of Hematology/Oncology. Dr. Hagedorn is currently an Instructor in Pediatrics at Boston Children’s Hospital and Harvard Medical School, where he has been working under the mentorship of Dr. Len Zon. Prior to moving to Boston, Dr. Hagedorn received […]

New Chief Fellows 2020-2021

Congratulations to Meredith Halpin, MD, and Raphael Szalat, MD, who have been selected as our new Chief Fellows for 2020-2021. It was an extremely close election, as we have a remarkably talented group of incoming senior fellows. We are very proud of all of them!

Ruben Dries, Ph.D., Accepts Offer to Join Section Faculty

We are happy to announce that Ruben Dries Ph.D., has accepted an offer to join our section. Dr. Dries’s research interests span the rapidly expanding fields of computational biology and transcriptomics. Using his expertise in these areas, he has made fundamental discoveries that have revealed new therapeutic vulnerabilities and mechanisms of drug resistance in a […]